The Scientific Foundation of the Spanish Association against Cancer (FCAECC, hereinafter) launches the largest national call with the aim of impacting on the mission of the organization in an innovative, measurable, flexible, and high impact manner. The focus of the AECC 70% Survivorship Challenge (Reto AECC 70% Supervivencia) is to promote nationwide, multidisciplinary consortium projects that generate impact in cancer survival, under excellence science, to respond to an unmet clinical need.

The focus of this call is to develop a project that responds to an unmet clinical need in cancers with a 5-year survival rate lower than 30% in Spain. The ultimate goal is to improve cancer patient survival, in cancers with broad national geographical distribution of the cases and secure access to patient samples.

Moreover, the results obtained must be able to generate equity in the whole national territory, in cancer patients, and increase the building capacities of researchers (clinical and translational) nationwide. The project should be designed as a consortium led by one or two coordinators and should have the appropriate scientific setting to be successfully developed.

Consortia are expected to join experts nationwide across different areas and thus, multidisciplinary/multisectoral teams (clinical, translational, academic) should be established.

Ver documento anexo (pág 4-8)

Valid national ID (Spanish applicants) or passport (all nationalities) scanned on both sides of the coordinator/coordinators.

Scientific pre-proposal: (maximum 6 pages) a description of the research project to be submitted. Template provided. PDF format.

* Important documents to be appended at the end of the scientific preproposal (they will not count in the extension limit):

• Commitment letters from international collaborations to express support to the pre-proposal
• Letter signed by the coordinator/s explaining public/private collaborations or agreements with companies, institutions, etc. (i.e., commercial partners) needed for the execution of the project.

Letter of commitment from the coordinating institution/s. The letter must state that in case of an award, a collaboration agreement will be signed between the coordinating institution and FCAECC. This letter must be signed by the Managing Director of the institution. The delivery of the Letter of Commitment without the required signature may imply the rejection of the application. In case the pre-proposal has two coordinators, one letter from each institution should be provided. PDF format.

Letter of commitment from coordinator/s with the agreement to commit at least 25% of their time to lead the program. In case the pre-proposal has two coordinators, the letter must include the identification of the coordinator responsible (leading applicant) for uploading the files and submitting the proposal in the FCAECC Grant Management System (GMS, hereinafter). In correspondence, his/her institution will be responsible for administrative issues. PDF format.

Curriculum Vitae of the coordinator/s (maximum 4 pages) using the CVA online editor from FECYT https://cvn.fecyt.es/editor/ or the Word template of this organization that must be provided in PDF format. The merits and contributions must be clearly reflected, especially in the publications (indicate the position in the list of authors and quartile of the journal), in research projects, and in patents. See the call document "CVA Instructions" for more information. PDF format.

Required documents in the full-proposal stage:

1. Scientific proposal: (maximum 30 pages) description of the research project including the first milestone action plan (12- 18 months). Template provided. PDF format.
2. Letter of commitment from the consolidated leaders where the researchers commit to lead the work packages. Template provided. PDF format.
3. Curriculum Vitae of the consolidated leaders (maximum 4 pages) using the CVA online editor from FECYT https://cvn.fecyt.es/editor/ or the Word template of this organization that must be provided in PDF format. The merits and contributions must be clearly reflected, especially in the publications (indicate the position in the list of authors and quartile of the journal), in research projects, and in patents. See the call document "CVA Instructions" for more information. PDF format.
4. Dissemination Report in non-scientific language so that it can be evaluated by cancer patients, survivors and/or relatives belonging to the AECC Patient Advocate program. Template provided. PDF format.
5. Explanatory video lasting no more than 5 minutes, summarizing the objectives of the project and the scope of the expected results at a scientific level. The video must be provided electronically in a legible format (MP4 with audio in English), ensuring good audiovisual quality.
6. Informative video of a duration of no more than 5 minutes, in which the objectives and scope of the results of the project are summarized in a nonscientific language so that the project can be valued by patients, survivors, and/or relatives of cancer belonging to the AECC Patient Advocate Program. The video must be provided electronically in a legible format (MP4 with audio in Spanish), ensuring good audiovisual quality.